"BAYPAT has been much more than a licensing partner for us."

From the very beginning, their team combined scientific excellence with commercial expertise and guided the technology transfer process with exceptional professionalism.

Their support was instrumental in enabling TRIMT to translate innovative αvβ6- and αvβ8-integrin targeting technologies from academia into industrial development and clinical application. Particularly during challenging negotiations involving multiple stakeholders, we could always rely on BAYPAT's prompt, professional, and solution-oriented support. I especially value their pragmatic, trustworthy, and collaborative approach. BAYPAT has been an outstanding partner in transforming world-class academic innovation into tangible value for patients.